PRAME expression and clinical outcome of breast cancer

Autor Epping, M T, Hart, A A M, Glas, A M, Krijgsman, O, Bernards, R
Vydáno 2008

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

Autor Weigelt, B, Bosma, A J, Hart, A A M, Rodenhuis, S, van 't Veer, L J
Vydáno 2003

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

Autor Kaas, R, Peterse, J L, Hart, A A M, Voogd, A C, Rutgers, E J T, van Leeuwen, F E
Vydáno 2003

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

Autor Bijker, N, Peterse, J L, Fentiman, I S, Julien, J-P, Hart, A A M, Avril, A, Cataliotti, L, Rutgers, E J T
Vydáno 2002

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

Autor Hoebers, F. J. P., Pluim, D., Hart, A. A. M., Verheij, M., Balm, A. J. M., Fons, G., Rasch, C. R. N., Schellens, J. H. M., Stalpers, L. J. A., Bartelink, H., Begg, A. C.
Vydáno 2007